The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can significantly improve symptoms.

Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology, today announced its participation in ...

Fenugreek seeds could be a gentle and effective option to help manage your eczema and improve your skin condition ...

The US Food and Drug Administration has approved Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 years and older with moderate-to-severe atopic dermatitis.

Studies show Black children are 1.7 times more likely to develop atopic dermatitis than white children (National Eczema Association). The 'It Takes a Village' campaign highlights the unique nuances ...

The Latiné diversity gap in dermatology has been highlighted as an issue, because it directly affects patient health. This ...

Recommendation based on a phase 3 study showing a significantly greater proportion of children on Dupixent achieved histological remission, compared to placebo, consistent with improvements seen in ...

Xite Practice Sales is proud to announce the successful sale of a Freestanding Emergency Room (ER)Center in Houston, Texas, to a rapidly expanding health insurance company with a ...

EMA committee recommends approval of Sanofi & Regeneron’s Dupixent to treat eosinophilic esophagitis in children as young as 1 year old: Paris Monday, September 23, 2024, 11:00 ...

Basophils IgE crosslinking is important for protective immunity against ticks and helminths, and for the development of various deleterious conditions: several allergic diseases including atopic ...

[18] In a postmarketing surveillance study, 109 (0.8%) of the 13,179 patients surveyed reported contact dermatitis (allergic vs irritant not specified). Patch testing, if performed, was not reported.